10x Genomics (TXG) News Today $13.32 -0.25 (-1.84%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period 10x Genomics and Beckman Coulter Life Sciences Launch New Solution to Automate Single Cell Assay WorkflowsNovember 20 at 4:15 AM | msn.com10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right NowNovember 20 at 4:15 AM | msn.comLMR Partners LLP Invests $1.59 Million in 10x Genomics, Inc. (NASDAQ:TXG)LMR Partners LLP acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 70,303 shares of the company's stock, valued at apprNovember 19 at 5:36 AM | marketbeat.com10x Genomics (NASDAQ:TXG) Hits New 52-Week Low - What's Next?10x Genomics (NASDAQ:TXG) Reaches New 1-Year Low - Here's WhyNovember 15, 2024 | marketbeat.comBaillie Gifford & Co. Reduces Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Baillie Gifford & Co. reduced its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 98.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 40,378 shares of the company's stock after selling 2,701,775 shares duNovember 14, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Receives $29.19 Consensus Price Target from AnalystsNovember 14, 2024 | americanbankingnews.comSumitomo Mitsui Trust Group Inc. Has $143.91 Million Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Sumitomo Mitsui Trust Group Inc. lifted its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 3.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,373,212 shares of the company's stock aftNovember 13, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Stock Quotes, Forecast and News SummaryNovember 13, 2024 | benzinga.com10x Genomics, Inc. (NASDAQ:TXG) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of 10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seventeen ratings firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, seven have issued a hoNovember 11, 2024 | marketbeat.comARK Investment Management LLC Grows Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)ARK Investment Management LLC boosted its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 15.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,750,345 shares of the company's stock after buying an addNovember 8, 2024 | marketbeat.com10x Genomics to Present at the Wolfe Research 2024 Healthcare ConferenceNovember 7, 2024 | prnewswire.comEarnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their ForecastsNovember 2, 2024 | finance.yahoo.com10x Genomics price target lowered to $19 from $21 at BarclaysNovember 2, 2024 | markets.businessinsider.com10x Genomics (NASDAQ:TXG) Price Target Cut to $19.00 by Analysts at BarclaysBarclays cut their price objective on shares of 10x Genomics from $21.00 to $19.00 and set an "overweight" rating on the stock in a report on Friday.November 1, 2024 | marketbeat.comFY2024 EPS Estimates for 10x Genomics Boosted by Analyst10x Genomics, Inc. (NASDAQ:TXG - Free Report) - Stock analysts at Leerink Partnrs upped their FY2024 EPS estimates for 10x Genomics in a report released on Tuesday, October 29th. Leerink Partnrs analyst P. Souda now anticipates that the company will earn ($1.46) per share for the year, up from thNovember 1, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Purchases 37,326 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Allspring Global Investments Holdings LLC lifted its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 2,280.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 38,963 shares of the company's stock after purchasinNovember 1, 2024 | marketbeat.com10x Genomics’ Visium HD selected by TechBio startup Cure51October 31, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Atricure (ATRC), 10x Genomics (TXG) and Chugai Pharmaceutical Co (OtherCHGCF)October 31, 2024 | markets.businessinsider.com10X Genomics CEO Serge Saxonov Initiates Rule 10b5-1 Trading Plan Amid Strategic Financial ManeuveringOctober 31, 2024 | markets.businessinsider.comTechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery InitiativeOctober 31, 2024 | prnewswire.com10x Genomics, Inc.: 10x Genomics Reports Third Quarter 2024 Financial ResultsOctober 31, 2024 | finanznachrichten.deBuy Rating on 10x Genomics: Strategic Restructuring and Long-term Growth ProspectsOctober 31, 2024 | markets.businessinsider.comStifel Nicolaus Remains a Buy on 10x Genomics (TXG)October 31, 2024 | markets.businessinsider.comCitigroup Cuts 10x Genomics (NASDAQ:TXG) Price Target to $23.00Citigroup reduced their price target on shares of 10x Genomics from $35.00 to $23.00 and set a "buy" rating on the stock in a research report on Wednesday.October 30, 2024 | marketbeat.comThese Analysts Boost Their Forecasts On 10x Genomics After Q3 ResultsOctober 30, 2024 | benzinga.com10x Genomics Reports Mixed Q3 2024 ResultsOctober 30, 2024 | markets.businessinsider.com10x Genomics: Buy Rating Amid Short-term Disruptions and Long-term Growth ProspectsOctober 30, 2024 | markets.businessinsider.com10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS10x Genomics (NASDAQ:TXG - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.30) EPS for the quarter, topping the consensus estimate of ($0.34) by $0.04. 10x Genomics had a negative net margin of 37.90% and a negative return on equity of 28.23%. The company had revenue of $151.65 million during the quarter, compared to analysts' expectations of $158.84 million. During the same quarter in the previous year, the company earned ($0.51) EPS. 10x Genomics's revenue was down 1.3% on a year-over-year basis.October 30, 2024 | marketbeat.com10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...October 30, 2024 | finance.yahoo.com10x Genomics: Balancing Market Challenges and Strategic OpportunitiesOctober 30, 2024 | markets.businessinsider.com10x Genomics Navigates Revenue Dip with New LaunchesOctober 30, 2024 | markets.businessinsider.com10x Genomics, Inc. 2024 Q3 - Results - Earnings Call PresentationOctober 29, 2024 | seekingalpha.com10x Genomics Reports Third Quarter 2024 Financial ResultsOctober 29, 2024 | prnewswire.com38,829 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Lecap Asset Management Ltd.Lecap Asset Management Ltd. acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 38,829 shares of the company's stock, valued at approxOctober 24, 2024 | marketbeat.comPacBio includes Onso platform in 10x Genomics Compatible Partner ProgramOctober 23, 2024 | markets.businessinsider.com10x Genomics (TXG) Scheduled to Post Earnings on Tuesday10x Genomics (NASDAQ:TXG) will be releasing earnings after the market closes on Tuesday, October 29, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634336)October 22, 2024 | marketbeat.comStrategic Pricing and Market Expansion Drive 10x Genomics Buy RatingOctober 16, 2024 | markets.businessinsider.comTD Cowen Reaffirms Their Hold Rating on 10x Genomics (TXG)October 16, 2024 | markets.businessinsider.comSG Americas Securities LLC Sells 77,766 Shares of 10x Genomics, Inc. (NASDAQ:TXG)SG Americas Securities LLC cut its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 76.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 23,578 shares of the company's stock after selling 77,766 shares duringOctober 16, 2024 | marketbeat.com10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium LaunchesOctober 15, 2024 | prnewswire.com10x Genomics (NASDAQ:TXG) PT Lowered to $21.00Barclays lowered their price objective on shares of 10x Genomics from $24.00 to $21.00 and set an "overweight" rating for the company in a research report on Tuesday.October 15, 2024 | marketbeat.com10x Genomics: Deciphering The Preliminary Q3 EarningsOctober 12, 2024 | seekingalpha.comBiggest stock movers Thursday: TLRY, GXO, TXG, and moreOctober 12, 2024 | msn.comTemporary Disruption at 10x Genomics: A Buy Rating Amidst Sales Force Realignment and Strong Product FundamentalsOctober 11, 2024 | markets.businessinsider.comTD Cowen Sticks to Its Hold Rating for 10x Genomics (TXG)October 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for 10x Genomics Amidst Long-Term Growth Potential Despite Short-Term ChallengesOctober 11, 2024 | markets.businessinsider.comStephens Reiterates Overweight Rating for 10x Genomics (NASDAQ:TXG)Stephens reissued an "overweight" rating and set a $30.00 price objective on shares of 10x Genomics in a research note on Thursday.October 10, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) PT Lowered to $20.00 at Canaccord Genuity GroupCanaccord Genuity Group cut their target price on shares of 10x Genomics from $32.00 to $20.00 and set a "buy" rating for the company in a report on Thursday.October 10, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Reaches New 1-Year Low - What's Next?10x Genomics (NASDAQ:TXG) Reaches New 1-Year Low - Should You Sell?October 10, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Stock, Short Interest ReportOctober 10, 2024 | benzinga.com Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. TXG Media Mentions By Week TXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXG News Sentiment▼0.620.46▲Average Medical News Sentiment TXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXG Articles This Week▼45▲TXG Articles Average Week Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cytek Biosciences News EyePoint Pharmaceuticals News Standard BioTools News Pacific Biosciences of California News Quanterix News Nautilus Biotechnology News Seer News Akoya Biosciences News Harvard Bioscience News Singular Genomics Systems News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
